Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanda Salutari

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Virchows Archiv : an International Journal of Pathology|April 21, 2021
Neuroendocrine tumor (NET) of the vagina in the light of WHO 2020 2-tiered grading system: clinicopathological report of the first described caseFrediano Inzani, Angela Santoro, Giuseppe Angelico, et al.
Immunology|November 25, 2003
Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoireAlessandra Battaglia, Gabriella Ferrandina, Alessia Buzzonetti, et al.
Journal of Ovarian Research|January 30, 2019
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational statusAngiolo Gadducci, Valentina Guarneri, Fedro Alessandro Peccatori, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 6, 2023
Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: a retrospective single-center experienceVanda Salutari, Viola Ghizzoni, Maria Vittoria Carbone, et al.
Critical Reviews in Oncology/Hematology|March 16, 2026
Homologous recombination deficiency in Ovarian Cancer: The Game-Changer for First-Line Maintenance TherapyMaria Chiara Cannizzaro, Angelo Minucci, Konstantinos Zormpas-Petridis, et al.
Oncology Reports|October 10, 2003
Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancerGabriella Ferrandina, Franco Oreste Ranelletti, Libero Lauriola, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Immunotherapy in gynecological cancersDomenica Lorusso, Valentina Ceni, Gennaro Daniele, et al.
Minerva Medica|May 25, 2019
New medical approaches in advanced ovarian cancerGiacomo Corrado, Eleonora Palluzzi, Carolina Bottoni, et al.
Cancer Treatment Reviews|October 17, 2020
Newly diagnosed ovarian cancer: Which first-line treatment?Domenica Lorusso, Valentina Ceni, Gennaro Daniele, et al.
Gynecologic Oncology|February 10, 2004
Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesionsGabriella Ferrandina, Franco Oreste Ranelletti, Vanda Salutari, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Virchows Archiv : an International Journal of Pathology|April 21, 2021
Neuroendocrine tumor (NET) of the vagina in the light of WHO 2020 2-tiered grading system: clinicopathological report of the first described caseFrediano Inzani, Angela Santoro, Giuseppe Angelico, et al.
Immunology|November 25, 2003
Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoireAlessandra Battaglia, Gabriella Ferrandina, Alessia Buzzonetti, et al.
Journal of Ovarian Research|January 30, 2019
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational statusAngiolo Gadducci, Valentina Guarneri, Fedro Alessandro Peccatori, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 6, 2023
Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: a retrospective single-center experienceVanda Salutari, Viola Ghizzoni, Maria Vittoria Carbone, et al.
Critical Reviews in Oncology/Hematology|March 16, 2026
Homologous recombination deficiency in Ovarian Cancer: The Game-Changer for First-Line Maintenance TherapyMaria Chiara Cannizzaro, Angelo Minucci, Konstantinos Zormpas-Petridis, et al.
Oncology Reports|October 10, 2003
Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancerGabriella Ferrandina, Franco Oreste Ranelletti, Libero Lauriola, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Immunotherapy in gynecological cancersDomenica Lorusso, Valentina Ceni, Gennaro Daniele, et al.
Minerva Medica|May 25, 2019
New medical approaches in advanced ovarian cancerGiacomo Corrado, Eleonora Palluzzi, Carolina Bottoni, et al.
Cancer Treatment Reviews|October 17, 2020
Newly diagnosed ovarian cancer: Which first-line treatment?Domenica Lorusso, Valentina Ceni, Gennaro Daniele, et al.
Gynecologic Oncology|February 10, 2004
Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesionsGabriella Ferrandina, Franco Oreste Ranelletti, Vanda Salutari, et al.
Pageof 11